NBIX vs SATLW
Neurocrine Biosciences Inc (NBIX) versus Satellogic Inc. Warrant (SATLW) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Satellogic Inc. Warrant (SATLW) common stock listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
SATLW does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SATLW currently screens at market cap $0.
Not investment advice. Open the NBIX and SATLW stock pages for the full models.
Not investment advice.